These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9367357)

  • 21. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.
    Feighny R; Burrous J; Putnak R
    Am J Trop Med Hyg; 1994 Mar; 50(3):322-8. PubMed ID: 8147490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
    Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
    Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein.
    Staropoli I; Clément JM; Frenkiel MP; Hofnung M; Deubel V
    J Virol Methods; 1996 Feb; 56(2):179-89. PubMed ID: 8882648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli.
    Mason PW; Zügel MU; Semproni AR; Fournier MJ; Mason TL
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2107-14. PubMed ID: 1698924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
    Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
    Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
    Bernardo L; Izquierdo A; Alvarez M; Rosario D; Prado I; López C; Martínez R; Castro J; Santana E; Hermida L; Guillen G; Guzmán MG
    Antiviral Res; 2008 Nov; 80(2):194-9. PubMed ID: 18602424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice.
    Izquierdo A; García A; Lazo L; Gil L; Marcos E; Alvarez M; Valdés I; Hermida L; Guillén G; Guzmán MG
    Arch Virol; 2014 Oct; 159(10):2597-604. PubMed ID: 24841761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated process for the purification and immobilization of the envelope protein domain III of dengue virus type 2 expressed in Rachiplusia nu larvae and its potential application in a diagnostic assay.
    Smith ME; Targovnik AM; Cerezo J; Morales MA; Miranda MV; Talou JR
    Protein Expr Purif; 2017 Mar; 131():76-84. PubMed ID: 27888023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and function analysis of dengue virus type 1 to 4 envelope domain III recombinant fusion protein].
    Niu GY; Lu P; Zhang S; Zhang QF; Li C; Liang MF; Xu F; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):161-4. PubMed ID: 21186514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the dengue virus envelope glycoprotein expressed in Pichia pastoris.
    Tan BH; Fu JL; Sugrue RJ
    Methods Mol Biol; 2007; 379():163-76. PubMed ID: 17502678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusion.
    Rozen-Gagnon K; Moreland NJ; Ruedl C; Vasudevan SG
    Protein Expr Purif; 2012 Mar; 82(1):20-5. PubMed ID: 22100526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles.
    Hsieh SC; Liu IJ; King CC; Chang GJ; Wang WK
    Virology; 2008 May; 374(2):338-50. PubMed ID: 18252258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
    Goncalvez AP; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
    Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
    J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.
    Suzarte E; Marcos E; Gil L; Valdés I; Lazo L; Ramos Y; Pérez Y; Falcón V; Romero Y; Guzmán MG; González S; Kourí J; Guillén G; Hermida L
    Arch Virol; 2014 Jul; 159(7):1629-40. PubMed ID: 24420159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates.
    Hermida L; Bernardo L; Martín J; Alvarez M; Prado I; López C; Sierra Bde L; Martínez R; Rodríguez R; Zulueta A; Pérez AB; Lazo L; Rosario D; Guillén G; Guzmán MG
    Vaccine; 2006 Apr; 24(16):3165-71. PubMed ID: 16490289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice.
    Zulueta A; Martín J; Hermida L; Alvarez M; Valdés I; Prado I; Chinea G; Rosario D; Guillén G; Guzmán MG
    Virus Res; 2006 Oct; 121(1):65-73. PubMed ID: 16781791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.